Animal models for analyzing metabolic syndrome‐associated liver diseases

Metabolic syndrome (MS) is a worldwide healthcare issue and a dominant risk factor for the development of incurable diseases affecting the entire body. The hepatic manifestations of MS include nonalcoholic fatty liver disease (NAFLD) and its progressive variant, nonalcoholic steatohepatitis (NASH)....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pathology international 2017-11, Vol.67 (11), p.539-546
Hauptverfasser:	Tsuneyama, Koichi, Nishitsuji, Kazuchika, Matsumoto, Minoru, Kobayashi, Tomoko, Morimoto, Yuki, Tsunematsu, Takaaki, Ogawa, Hirohisa
Format:	Artikel
Sprache:	eng
Schlagworte:	animal model Animal models Animals Carcinogenesis Carcinogens Cirrhosis Diabetes Diabetes mellitus Disease Models, Animal Fatty liver Health care hepatocelluar carcinoma Hepatocellular carcinoma Liver Liver cirrhosis Liver diseases Liver Diseases - etiology Liver Diseases - pathology Metabolic syndrome Metabolic Syndrome - complications Mice nonalcoholic steatohepatitis Obesity Pathogenesis Risk factors Rodents
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!